Post-transplant T cell chimerism predicts graft versus host disease but not disease relapse in patients undergoing an alemtuzumab based reduced intensity conditioned allogeneic transplant

✍ Scribed by Nikolousis, E.; Robinson, S.; Nagra, S.; Brookes, C.; Kinsella, F.; Tauro, S.; Jeffries, S.; Griffiths, M.; Mahendra, P.; Cook, M.; Paneesha, S.; Lovell, R.; Kishore, B.; Chaganti, S.; Malladi, R.; Raghavan, M.; Moss, P.; Milligan, D.; Craddock, C.

• Book ID: 121326064
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 297 KB
• Volume: 37
• Category: Article
• ISSN: 0145-2126
• DOI: 10.1016/j.leukres.2013.01.010